Featured Research

from universities, journals, and other organizations

Nanomaterials key to developing stronger artificial hearts

Date:
January 31, 2013
Source:
Brigham and Women's Hospital
Summary:
A new study details the creation of innovative cardiac patches that utilize nanotechnology to enhance the conductivity of materials to induce cardiac tissue formation. Creation of these ultra-thin cardiac patches put medicine a step closer to durable, high-functioning artificial tissues that could be used to repair damaged hearts and other organs.

ACS Nano published a study by Ali Khademhosseini, PhD, MASc, a researcher in the division of biomedical engineering at Brigham and Women's Hospital, detailing the creation of innovative cardiac patches that utilize nanotechnology to enhance the conductivity of materials to induce cardiac tissue formation.

Creation of these ultra-thin cardiac patches put medicine a step closer to durable, high-functioning artificial tissues that could be used to repair damaged hearts and other organs.

The cardiac tissue patches utilize a hydrogel scaffolding reinforced by nanomaterials called carbon nanotubes. To create the patches, the researchers seeded neonatal rat heart muscle tissue onto carbon nanotube-infused hydrogels. These novel patches showed excellent mechanical integrity and advanced electrophysiological functions. Moreover, they demonstrated a protective effect against chemicals toxic to heart tissue.


Story Source:

The above story is based on materials provided by Brigham and Women's Hospital. Note: Materials may be edited for content and length.


Journal Reference:

  1. Su Ryon Shin, Sung Mi Jung, Momen Zalabany, Keekyoung Kim, Pinar Zorlutuna, Sang bok Kim, Mehdi Nikkhah, Masoud Khabiry, Mohamed Azize, Jing Kong, Kai-tak Wan, Tomas Palacios, Mehmet R Dokmeci, Hojae Bae, Xiaowu (Shirley) Tang, Ali Khademhosseini. Carbon-Nanotube-Embedded Hydrogel Sheets for Engineering Cardiac Constructs and Bioactuators. ACS Nano, 2013; 130130092038000 DOI: 10.1021/nn305559j

Cite This Page:

Brigham and Women's Hospital. "Nanomaterials key to developing stronger artificial hearts." ScienceDaily. ScienceDaily, 31 January 2013. <www.sciencedaily.com/releases/2013/01/130131144448.htm>.
Brigham and Women's Hospital. (2013, January 31). Nanomaterials key to developing stronger artificial hearts. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/01/130131144448.htm
Brigham and Women's Hospital. "Nanomaterials key to developing stronger artificial hearts." ScienceDaily. www.sciencedaily.com/releases/2013/01/130131144448.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins